Cargando…

The Market Dynamics of Generic Medicines in the Private Sector of 19 Low and Middle Income Countries between 2001 and 2011: A Descriptive Time Series Analysis

This observational study investigates the private sector, retail pharmaceutical market of 19 low and middle income countries (LMICs) in Latin America, Asia and the Middle East/South Africa analyzing the relationships between volume market share of generic and originator medicines over a time series...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaplan, Warren A., Wirtz, Veronika J., Stephens, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3787029/ https://www.ncbi.nlm.nih.gov/pubmed/24098644 http://dx.doi.org/10.1371/journal.pone.0074399

Ejemplares similares

Challenges constraining access to insulin in the private-sector market of Delhi, India
por: Sharma, Abhishek, et al.
Publicado: (2016)

The Brazilian private pharmaceutical market after the first ten years of the generics law
por: Bertoldi, Andréa Dâmaso, et al.
Publicado: (2019)

Contracting retail pharmacies as a source of essential medicines for public sector clients in low- and middle-income countries: a scoping review of key considerations, challenges, and opportunities
por: Kaplan, Warren A., et al.
Publicado: (2023)

Economic costs of childhood stunting to the private sector in low- and middle-income countries
por: Akseer, Nadia, et al.
Publicado: (2022)

Comparison of medicines management strategies in insurance schemes in middle-income countries: four case studies
por: Kaplan, Warren A., et al.
Publicado: (2017)

The role of the private sector in noncommunicable disease prevention and management in low- and middle-income countries: a series of systematic reviews and thematic syntheses
por: Marshall, Keiko, et al.
Publicado: (2023)

Outcomes of HIV treatment from the private sector in low-income and middle-income countries: a systematic review protocol
por: Mburu, Gitau, et al.
Publicado: (2020)

Private sector, for-profit health providers in low and middle income countries: can they reach the poor at scale?
por: Tung, Elizabeth, et al.
Publicado: (2014)

Estimating private sector out-of-pocket expenditures on family planning commodities in low-and-middle-income countries
por: Weinberger, Michelle, et al.
Publicado: (2021)

Private sector delivery of maternal and newborn health care in low-income and middle-income countries: a scoping review protocol
por: Lattof, Samantha R, et al.
Publicado: (2021)

Implications of private sector Hib vaccine coverage for the introduction of public sector Hib-containing pentavalent vaccine in India: evidence from retrospective time series data
por: Sharma, Abhishek, et al.
Publicado: (2015)

Availability of anticancer medicines in public and private sectors, and their affordability by low, middle and high-income class patients in Pakistan
por: Sarwar, Muhammad Rehan, et al.
Publicado: (2018)

SARS-CoV-2 testing in low- and middle-income countries: availability and affordability in the private health sector
por: Faust, Lena, et al.
Publicado: (2020)

Impacts of intellectual property provisions in trade treaties on access to medicine in low and middle income countries: a systematic review
por: Islam, Md. Deen, et al.
Publicado: (2019)

Broken drug markets in infectious diseases: Opportunities outside the private sector?
por: Alpern, Jonathan D., et al.
Publicado: (2019)

India's family planning market and opportunities for the private sector: An analysis using the total market approach
por: Mozumdar, Arupendra, et al.
Publicado: (2019)

The private sector market for malaria rapid diagnostic tests in Nigeria: results of the 2018 market survey
por: Edwards, Hannah M., et al.
Publicado: (2022)

Challenges of medicines management in the public and private sector under Ghana’s National Health Insurance Scheme – A qualitative study
por: Ashigbie, Paul G., et al.
Publicado: (2016)

Understanding the decision making process of selection of medicines in the private sector in South Africa – lessons for low-middle income countries
por: Perumal-Pillay, Velisha Ann, et al.
Publicado: (2020)

Do newly marketed generic medicines expand markets using descriptive time series analysis and mixed logit models? Korea as an exemplar and its implications
por: Kwon, Hye-Young, et al.
Publicado: (2016)

Evaluation of the effects of a generic substitution policy implemented in Chile
por: Mansilla, Cristián, et al.
Publicado: (2019)

Purchase and use of antimicrobials in the hospital sector of Vietnam, a lower middle-income country with an emerging pharmaceuticals market
por: Dat, Vu Quoc, et al.
Publicado: (2020)

Innovative health service delivery models in low and middle income countries - what can we learn from the private sector?
por: Bhattacharyya, Onil, et al.
Publicado: (2010)

The impact of a private sector living wage intervention on consumption and cardiovascular disease risk factors in a middle income country
por: Rehkopf, David H., et al.
Publicado: (2018)

Delivering child health interventions through the private sector in low and middle income countries: challenges, opportunities, and potential next steps
por: Awor,, Phyllis, et al.
Publicado: (2018)

Experiences of private sector quality care amongst mothers, newborns, and children in low- and middle-income countries: a systematic review
por: Strong, Joe, et al.
Publicado: (2021)

The implementation of the bioequivalence certification policy in Chile: An analysis of market authorization data
por: Kaplan, Warren A., et al.
Publicado: (2019)

The stability of ethnic identity in England and Wales 2001–2011
por: Simpson, Ludi, et al.
Publicado: (2016)

Erratum to: Do newly marketed generic medicines expand markets using descriptive time series analysis and mixed logit models? Korea as an exemplar and its implications
por: Kwon, Hye-Young, et al.
Publicado: (2017)

Private sector delivery of quality care for maternal, newborn and child health in low-income and middle-income countries: a mixed-methods systematic review protocol
por: Lattof, Samantha R, et al.
Publicado: (2020)

The impact of the private sector co-payment mechanism (PSCM) on the private market for ACT in Nigeria: results of the 2018 cross-sectional outlet and household market surveys
por: Edwards, Hannah M., et al.
Publicado: (2022)

Analysis of the Korean generic medicine market: Factors affecting the market share of generic medicines
por: Kim, Dong‐Sook, et al.
Publicado: (2021)

The costs of diabetes treatment in low- and middle-income countries: a systematic review
por: Moucheraud, Corrina, et al.
Publicado: (2019)

Improved malaria case management in formal private sector through public private partnership in Ethiopia: retrospective descriptive study
por: Argaw, Mesele D., et al.
Publicado: (2016)

A systematic tale of two differing reviews: evaluating the evidence on public and private sector quality of primary care in low and middle income countries
por: Coarasa, Jorge, et al.
Publicado: (2017)

Health seeking behaviours and private sector delivery of care for non-communicable diseases in low- and middle-income countries: protocol for a systematic review
por: Brindley, Callum, et al.
Publicado: (2023)

Assessment of prescribing information for generic drugs manufactured in the Middle East and marketed in Saudi Arabia
por: Gebran, Nicole, et al.
Publicado: (2006)

Socially-marketed rapid diagnostic tests and ACT in the private sector: ten years of experience in Cambodia
por: Yeung, Shunmay, et al.
Publicado: (2011)

Interrupted time-series analysis of the impact of generic market entry of antineoplastic products in China
por: Guan, Xiaodong, et al.
Publicado: (2018)

Role of Private Enterprise in Cancer Control in Low to Middle Income Countries
por: Nwogu, Chukwumere E., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_253bthtrpc77sj9s85k4v6pc7k